The latest Alzheimer’s clinical trial in South Florida illustrates a trend: More and more, researchers are seeking younger, healthier patients — people in the disease’s early stages or who don’t even have the neurological disorder but may be at risk for it.

That’s because Alzheimer’s disease researchers now believe studies have started too late in the process, when brain changes are so advanced that there is little any treatment could do, said Dr. Harvey D. Schwartz, a neurologist at Infinity Clinical Research in Hollywood. 

READ FULL ARTICLE Curated publisher From Sun Sentinel